BioSpace News Archive

Rhythmlink Launches FDA Cleared MR Conditional*/CT Quick Connect System Product Line

Rhythmlink announced the release of a new product line designed to maximize efficiency and workflow when recording EEG on patients who require MR or CT imaging.

December 6, 2017

·

4 min read

Business

CanniMed Therapeutics Announces Medical Cannabis Supply Agreement with PharmaChoice

Pursuant to the agreement, PharmaChoice has committed exclusively to CanniMed as its sole supplier of cannabis products, subject to CanniMed meeting certain product and volume requirements.

December 6, 2017

·

5 min read

Biotech Beach

Viking Therapeutics Announces Pricing of $12.8 Million Public Offering of Common Stock

Gross proceeds, before underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $12.8M.

December 6, 2017

·

5 min read

Biotech Beach

Odonate Therapeutics Announces Pricing of 6,250,000 Shares of Initial Public Offering

Odonate Therapeutics announced the pricing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $24.00 per share for aggregate gross proceeds of approximately $150 million.

December 6, 2017

·

2 min read

Deals

Quanterix Corporation Announces Pricing of Initial Public Offering

Quanterix Corporation announced the pricing of its initial public offering of 4,275,200 shares of its common stock at a public offering price of $15.00 per share for aggregate gross proceeds of $64,128,000.

December 6, 2017

·

3 min read

Business

Proteros biostructures GmbH Names Dave Lemus as New Executive Board Member

Previous to his appointment, Mr. Lemus was COO and CFO of Medigene AG, assisting in its transformation into an immunotherapy-based company through the establishment of strategic partnerships.

December 6, 2017

·

2 min read

Business

DermTech Announces Addition of Ronald Moy to Scientific Advisory Board

He is a leader in the field of dermatology as a past President of the American Academy of Dermatology, Pacific Dermatologic Association and American Society for Dermatologic Surgery and as Vice President of the Skin Cancer Foundation.

December 6, 2017

·

2 min read

Business

TapImmune Appoints Richard Kenney, M.D., F.A.C.P., as Acting CMO

In this newly created role at TapImmune, Dr. Kenney will continue to manage the Company’s ongoing and planned clinical programs for its novel, multi-epitope, T-cell vaccine candidates.

December 6, 2017

·

5 min read

New Data Shows Vestagen’s VESTEX Repels Fluids and Reduces Pathogen Bioburden on the Fabric by More than 99% Compared to Conventional Scrubs

Vestagen today announced that the protective properties of VESTEX will be discussed in two scientific presentations at the upcoming IHI 2017 National Forum on Quality Improvement in Health Care conference being held December 10-13 in Orlando, FL.

December 6, 2017

·

7 min read

Drug Development

Alpine Immune Sciences Announces Preclinical Data Showing Novel Immuno-Oncology Costimulatory Molecules Generated from vIgD Platform Fused with Trastuzumab Enhanced Immune Responses Against HER2-Positive Tumor Cells

Results showed these trastuzumab-ICOSL “V-mAbs” promoted T cell proliferation and cytokine secretion and enhanced killing of tumor cells.

December 6, 2017

·

5 min read